Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

被引：224
作者：
Kerr, K. M. [1 ,2 ]
Bubendorf, L. [3 ]
Edelman, M. J. [4 ]
Marchetti, A. [5 ]
Mok, T. [6 ]
Novello, S. [7 ]
O'Byrne, K. [8 ,9 ]
Stahel, R. [10 ]
Peters, S. [11 ]
Felip, E. [12 ]
机构：
[1] Aberdeen Royal Infirm, Dept Pathol, Aberdeen, Scotland
[2] Aberdeen Univ Med Sch, Aberdeen, Scotland
[3] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland
[4] Univ New Mexico Canc Ctr, Albuquerque, NM USA
[5] Univ Fdn, Ctr Predict Mol Med, Ctr Excellence Ageing, Chieti, Italy
[6] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[7] Univ Turin, Azienda Osped Univ San Luigi Orbassano, Dept Oncol, Thorac Oncol Unit, I-10124 Turin, Italy
[8] Trinity Coll Dublin, Dublin, Ireland
[9] Queensland Univ Technol, Brisbane, Qld 4001, Australia
[10] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland
[11] CHU Vaudois, Dept Oncol, Lausanne, Switzerland
[12] Vall dHebron Univ Hosp, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷 / 09期
关键词：
ESMO; consensus; non-small-cell lung cancer; pathology; molecular testing; recommendations; MESSENGER-RNA EXPRESSION; IN-SITU HYBRIDIZATION; EXTERNAL QUALITY ASSESSMENT; FACTOR RECEPTOR MUTATIONS; ALK GENE REARRANGEMENTS; EML4-ALK FUSION GENE; PHASE-III TRIAL; BRONCHIAL BIOPSY; INTERNATIONAL-ASSOCIATION; HISTOLOGICAL CLASSIFICATION;
D O I：
10.1093/annonc/mdu145
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The Second ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on management of patients with non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, early stage disease, locally advanced disease and advanced (metastatic) disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on recommendations for pathology and molecular biomarkers in relation to the diagnosis of lung cancer, primarily non-small-cell carcinomas.
引用
收藏
页码：1681 / 1690
页数：10
相关论文
共 50 条
[41]   Molecular Pathology of Primary Non-small Cell Lung Cancer [J].
Suster, David Ilan ;
Mino-Kenudson, Mari .
ARCHIVES OF MEDICAL RESEARCH, 2020, 51 (08) :784-798
[42]   Updates in the molecular pathology of non-small cell lung cancer [J].
Paver, Elizabeth ;
O'Toole, Sandra ;
Cheng, Xin Min ;
Mahar, Annabelle ;
Cooper, Wendy A. .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2021, 38 (05) :54-61
[43]   Molecular predictive and prognostic markers in non-small-cell lung cancer [J].
Coate, Linda E. ;
John, Thomas ;
Tsao, Ming-Sound ;
Shepherd, Frances A. .
LANCET ONCOLOGY, 2009, 10 (10) :1001-1010
[44]   Molecular targeted therapy of patients with non-small-cell lung cancer [J].
Stencel, Katarzyna ;
Swiniuch, Daria ;
Ramlau, Rodryg .
ONCOLOGY IN CLINICAL PRACTICE, 2019, 15 (06) :289-296
[45]   An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer [J].
Ku, Bo Mi ;
Sun, Jong-Mu ;
Lee, Se-hoon ;
Ahn, Jin Seok ;
Park, Keunchil ;
Ahn, Myung-Ju .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (10) :933-942
[46]   Targeting angiogenesis in advanced non-small-cell lung cancer: are biomarkers needed? [J].
G. Metro ;
M. Cenci ;
A. Baldi ;
L. Crinò .
Current Respiratory Care Reports, 2013, 2 (2) :72-78
[47]   New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology [J].
Isla, Dolores ;
Lozano, Maria D. ;
Paz-Ares, Luis ;
Salas, Clara ;
de Castro, Javier ;
Conde, Esther ;
Felip, Enriqueta ;
Gomez-Roman, Javier ;
Garrido, Pilar ;
Enguita, Ana Belen .
REVISTA ESPANOLA DE PATOLOGIA, 2023, 56 (02) :97-112
[48]   Targeting angiogenesis in advanced non-small-cell lung cancer: are biomarkers needed? [J].
Metro, G. ;
Cenci, M. ;
Baldi, A. ;
Crino, L. .
CURRENT PULMONOLOGY REPORTS, 2013, 2 (02) :72-78
[49]   New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology [J].
Isla, Dolores ;
Lozano, Maria D. ;
Paz-Ares, Luis ;
Salas, Clara ;
de Castro, Javier ;
Conde, Esther ;
Felip, Enriqueta ;
Gomez-Roman, Javier ;
Garrido, Pilar ;
Belen Enguita, Ana .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (05) :1252-1267
[50]   Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer [J].
Mozzoni, Paola ;
Banda, Iris ;
Goldoni, Matteo ;
Corradi, Massimo ;
Tiseo, Marcello ;
Acampa, Olga ;
Balestra, Valeria ;
Ampollini, Luca ;
Casalini, Angelo ;
Carbognani, Paolo ;
Mutti, Antonio .
BIOMARKERS, 2013, 18 (08) :679-686
12345